P. Kent Hawryluk - Net Worth and Insider Trading

P. Kent Hawryluk Net Worth

The estimated net worth of P. Kent Hawryluk is at least $61 dollars as of 2024-09-20. P. Kent Hawryluk is the Director of NeuroBo Pharmaceuticals Inc and owns about 19 shares of NeuroBo Pharmaceuticals Inc (NRBO) stock worth over $61. Details can be seen in P. Kent Hawryluk's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that P. Kent Hawryluk has not made any transactions after 2017-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of P. Kent Hawryluk

To

P. Kent Hawryluk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, P. Kent Hawryluk owns 1 companies in total, including NeuroBo Pharmaceuticals Inc (NRBO) .

Click here to see the complete history of P. Kent Hawryluk’s form 4 insider trades.

Insider Ownership Summary of P. Kent Hawryluk

Ticker Comapny Transaction Date Type of Owner
NRBO NeuroBo Pharmaceuticals Inc 2017-03-10 director

P. Kent Hawryluk Latest Holdings Summary

P. Kent Hawryluk currently owns a total of 1 stock. P. Kent Hawryluk owns 19 shares of NeuroBo Pharmaceuticals Inc (NRBO) as of March 10, 2017, with a value of $61.

Latest Holdings of P. Kent Hawryluk

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NRBO NeuroBo Pharmaceuticals Inc 2017-03-10 19 3.19 61

Holding Weightings of P. Kent Hawryluk


P. Kent Hawryluk Form 4 Trading Tracker

According to the SEC Form 4 filings, P. Kent Hawryluk has made a total of 0 transactions in NeuroBo Pharmaceuticals Inc (NRBO) over the past 5 years. The most-recent trade in NeuroBo Pharmaceuticals Inc is the acquisition of 4 shares on March 10, 2017, which cost P. Kent Hawryluk around $236,750.

Insider Trading History of P. Kent Hawryluk

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

P. Kent Hawryluk Trading Performance

GuruFocus tracks the stock performance after each of P. Kent Hawryluk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by P. Kent Hawryluk is 9.92%. GuruFocus also compares P. Kent Hawryluk's trading performance to market benchmark return within the same time period. The performance of stocks bought by P. Kent Hawryluk within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how P. Kent Hawryluk's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of P. Kent Hawryluk

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 27.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 29.25 LIMIT LIMIT LIMIT LIMIT LIMIT

P. Kent Hawryluk Ownership Network

Ownership Network List of P. Kent Hawryluk

No Data

Ownership Network Relation of P. Kent Hawryluk

Insider Network Chart

P. Kent Hawryluk Owned Company Details

What does NeuroBo Pharmaceuticals Inc do?

Who are the key executives at NeuroBo Pharmaceuticals Inc?

P. Kent Hawryluk is the director of NeuroBo Pharmaceuticals Inc. Other key executives at NeuroBo Pharmaceuticals Inc include 10 percent owner Dong-a St Co., Ltd , Acting Chief Financial Officer Marshall H Woodworth , and Interim CEO and President Joseph Hooker .

NeuroBo Pharmaceuticals Inc (NRBO) Insider Trades Summary

Over the past 18 months, P. Kent Hawryluk made no insider transaction in NeuroBo Pharmaceuticals Inc (NRBO). Other recent insider transactions involving NeuroBo Pharmaceuticals Inc (NRBO) include a net purchase of 5,089,060 shares made by Dong-a St Co., Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of NeuroBo Pharmaceuticals Inc (NRBO) in total and bought 5,089,060 shares, with a net purchase of 5,089,060 shares. During the past 18 months, 0 shares of NeuroBo Pharmaceuticals Inc (NRBO) were sold and 5,089,060 shares were bought by its insiders, resulting in a net purchase of 5,089,060 shares.

NeuroBo Pharmaceuticals Inc (NRBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NeuroBo Pharmaceuticals Inc Insider Transactions

No Available Data

P. Kent Hawryluk Mailing Address

Above is the net worth, insider trading, and ownership report for P. Kent Hawryluk. You might contact P. Kent Hawryluk via mailing address: 17199 N. Laurel Park Drive, Suite 401, Livonia Mi 48152.

Discussions on P. Kent Hawryluk

No discussions yet.